NGF and breast carcinoma: To investigate how well NGF can predict cancer progression and identify robust biomarkers, we selected a cohort of 295 nonfamilial breast cancer patients (van de Vijver dataset [41]), for 78 of whom metastasis has been detected during a follow-up visit within five years after surgery.